Segment Reporting (Tables)

6 Months Ended

Jun. 30, 2017

Segment Reporting [Abstract]

Summary Of Segment Performance

	For the Three Months Ended June 30,
		CAG	Water		LPD		Other		Unallocated Amounts		Consolidated Total
2017
Revenue	$	439,948	$	29,424	$	33,553	$	6,015	$	-	$	508,940
Income (loss) from operations	$	108,731	$	13,653	$	5,176	$	768	$	(5,764)	$	122,564
Interest expense, net												(7,979)
Income before provision for income taxes												114,585
Provision for income taxes												29,178
Net income												85,407
Less: Net income attributable to noncontrolling interest												50
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	85,357
2016
Revenue	$	400,223	$	27,829	$	32,856	$	5,661	$	-	$	466,569
Income (loss) from operations	$	91,019	$	12,743	$	5,069	$	(920)	$	(3,749)	$	104,162
Interest expense, net												(7,276)
Income before provision for income taxes												96,886
Provision for income taxes												29,680
Net income												67,206
Less: Net income attributable to noncontrolling interest												4
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	67,202

	For the Six Months Ended June 30,
		CAG	Water		LPD		Other		Unallocated Amounts		Consolidated Total
2017
Revenue	$	843,175	$	54,501	$	62,870	$	10,415	$	-	$	970,961
Income (loss) from operations	$	188,586	$	23,916	$	8,978	$	1,161	$	(7,834)	$	214,807
Interest expense, net												(15,485)
Income before provision for income taxes												199,322
Provision for income taxes												44,857
Net income												154,465
Less: Net income attributable to noncontrolling interest												89
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	154,376
2016
Revenue	$	757,862	$	51,381	$	63,712	$	11,164	$	-	$	884,119
Income (loss) from operations	$	152,397	$	22,422	$	9,639	$	(1,757)	$	(4,746)	$	177,955
Interest expense, net												(14,760)
Income before provision for income taxes												163,195
Provision for income taxes												49,964
Net income												113,231
Less: Net income attributable to noncontrolling interest												10
Net income attributable to IDEXX Laboratories, Inc. stockholders											$	113,221

Summary Of Revenue By Product And Service Category

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
		2017		2016		2017		2016
CAG segment revenue:
CAG Diagnostics recurring revenue:	$	380,319	$	338,653	$	726,999	$	644,494
IDEXX VetLab consumables		132,094		114,560		255,647		222,529
Rapid assay products		60,266		55,777		108,161		98,863
Reference laboratory diagnostic and consulting services		171,298		153,134		330,367		293,842
CAG Diagnostics service and accessories		16,661		15,182		32,824		29,260
CAG Diagnostics capital - instruments		27,716		32,165		53,899		54,808
Veterinary software, services and diagnostic imaging systems		31,913		29,405		62,277		58,560
CAG segment revenue		439,948		400,223		843,175		757,862
Water segment revenue		29,424		27,829		54,501		51,381
LPD segment revenue		33,553		32,856		62,870		63,712
Other segment revenue		6,015		5,661		10,415		11,164
Total revenue	$	508,940	$	466,569	$	970,961	$	884,119